Conflicting effects of caffeine on apoptosis and clonogenic survival of human K1 thyroid carcinoma cell lines with different p53 status after exposure to cisplatin or UVc irradiation

Biochemical and Biophysical Research Communications

Volumn 314, Issue 4, 2004, Pages 1100-1106

  Deplanque, G ^a   Ceraline J ^a   Lapouge, G ^a   Dufour, P ^a   Bergerat, J P ^a   Klein Soyer, C ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Apoptosis; Caffeine; Cisplatin; Clonogenic survival; p53 status; Thyroid cells

Indexed keywords

CAFFEINE; CISPLATIN; DNA; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL PROLIFERATION; CELL SURVIVAL; CHEMOSENSITIVITY; CLONOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DRUG EFFECT; DRUG EXPOSURE; DRUG SCREENING; FIBROBLAST; HUMAN; HUMAN CELL; IN VIVO STUDY; INHIBITION KINETICS; MOLECULE; MUTATION; PAPILLARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; RADIOSENSITIVITY; THYROID CARCINOMA; ULTRAVIOLET C RADIATION; ULTRAVIOLET IRRADIATION; WILD TYPE;

EID: 0942278959     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.006     Document Type: Article

References (32)

1. Waldren C.A., Rasko I. Caffeine enhancement of X-ray killing in cultured human and rodent cells. Radiat. Res. 73:1978;95-110.
2. cdc2 kinase. Nat. Med. 2:1996;1140-1143.
3. Ostertag W., Duisberg E., Stürmann M. The mutagenic activity of caffeine in man. Mutat. Res. 2:1965;293-296.
4. Walters R.A., Gurley L.R., Tobey R.A. Effect of caffeine on radiation-induced phenomena associated with cell-cycle traverse of mammalian cells. Biophys. J. 14:1974;99-118.
5. Levi-Schaffer F., Touitou E. Xanthines inhibit 3T3 fibroblast proliferation. Skin Pharmacol. 4:1991;286-290.
6. Murnane J.P. Cell cycle regulation in response to DNA damage in mammalian cells: a historical perspective. Cancer Metastasis Rev. 14:1995;17-29.
7. Takagi M., Shigeta T., Asada M., Iwata S., Nakazawa S., Kanke Y., Ishimoto K., Mizutani S. DNA damage-associated cell cycle and cell death control is differentially modulated by caffeine in clones with p53 mutations. Leukemia. 13:1999;70-77.
8. Russel K.J., Wiens L.W., Demers G.W., Galloway D.A., Plon S.E., Groudine M. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint competent cells. Cancer Res. 55:1995;1639-1642.
9. 2 delay. Cancer Res. 55(1):1995;1643-1648.
10. DeFrank J.S., Tang W., Powell S.N. p53-null cells are more sensitive to ultraviolet light only in the presence of caffeine. Cancer Res. 56:1996;5356-5368.
11. Sarkaria J.N., Busby E.C., Tibbetts R.S., Roos P., Taya Y., Karnitz L.M., Abraham R.T. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59:1999;4375-4382.
12. Winters Z.E., Ongkeko W.M., Harris A.L., Nordbury C.J. p53 regulates Cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cells. Oncogene. 17:1998;673-684.
13. Iliakis G., Wang Y., Guan J., Wang H. DNA damage checkpoint control in cells exposed to ionising radiation. Oncogene. 22:2003;5834-5847.
14. Hunter T. Protein kinases and phosphatases: the Yin and Yang of protein phosphorylation and signaling. Cell. 80:1995;225-236.
15. Ribeiro J.C.C., Barnetson A.R., Jackson P., Ow K., Links M., Russell P.J. Caffeine-increased radiosensitivity is not dependent on a loss of G2/M arrest or apoptosis in bladder cancer cell lines. Int. J. Radiat. Biol. 75:1999;481-492.
16. Deplanque G., Vincent F., Mah-Becherel M.C.M., Cazenave J.P., Bergerat J.P., Klein-Soyer C. Caffeine does not cause override of the G2/M block induced by UVc or gamma radiation in normal human skin fibroblasts. Br. J. Cancer. 83:2000;346-353.
17. Deplanque G., Céraline J., Mah-Becherel M.C.M., Cazenave J.P., Bergerat J.P., Klein-Soyer C. Caffeine and the G2/M block override: a concept resulting from a misleading cell kinetic delay, independent of functional p53. Int. J. Cancer. 94:2001;363-369.
18. Cortez D. Caffeine inhibits checkpoint responses without inhibiting the ataxia-telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) protein kinases. J. Biol. Chem. 278:2003;37139-37145.
19. Giaccia A.J., Kastan M.B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12:1998;2973-2983.
20. Wyllie F.S., Haughton M.F., Rowson J.M., Wynford-Thomas D. Human thyroid cancer cells as a source of iso-genic, iso-phenotypic cell lines with or without functional p53. Br. J. Cancer. 79:1999;1111-1120.
21. Céraline J., Deplanque G., Noël F., Natarajan-Amé S., Bergerat J.P., Klein-Soyer C. Sensitivity to cisplatin treatment of human K1 thyroid carcinoma cell lines with altered p53 function Cancer. Chemother. Pharmacol. 51:2003;91-95.
22. Bergerat J.P., Green C., Drewinko B. Combination chemotherapy in vitro. IV. Response of human colon carcinoma cells to combinations using. cis -diamminedichloroplatinum Cancer Biochem. Biophys. 3:1979;173-180.
23. Lelo A., Miners J.O., Robson R., Birkett D.J. Assessment of caffeine exposure: caffeine content of beverages, caffeine intake, and plasma concentrations of methylxanthines. Clin. Pharmacol. Ther. 39:1986;54-59.
24. Weiss J.F., Landauer M.R. Protection against ionizing radiation by antioxidant nutrients ans phytochemicals. Toxicology. 189:2003;1-20.
25. Asker C., Wiman K., Selivanova G. p53-induced apoptosis as a safeguard against cancer. Biochem. Biophys. Res. Commun. 265:1999;1-6.
26. Pujol J.L., Cuppissol D., Gestin-Boyer C., Bres J., Serrou B., Michel F.B. Tumor-tissue and plasma concentrations of platinum during chemotherapy of non-small-cell lung cancer patients. Cancer Chemother. Pharmacol. 27:1990;72-75.
27. Bernhard E.J., Muschel R.J., Bakanauskas V.J., McKenna W.G. Reducing the radiation-induced G2 delay causes HeLa cells to undergo apoptosis instead of mitotic death. Int. J. Radiat. Biol. 69:1996;575-584.
28. Janss A., Levow C., Bernhard E.J., Muschel R.J., McKenna W.G., Sutton L., Phillips P.C. Caffeine and staurosporine enhance the cytotoxicity of cisplatin and camptothecin in human brain tumor cell lines. Exp. Cell Res. 243:1998;29-38.
29. Zhen W., Vaughan A.T.M. Effects of caffeine on radiation-induced apoptosis in TK6 cells. Radiat. Res. 141:1995;170-175.
30. Rowley R., Zorch M., Leeper D.B. Effect of caffeine on radiation-induced mitotic delay: delayed expression of G2 arrest. Radiat. Res. 97:1984;178-185.
31. Barnes A.R., Hebron B.S., Smith J. Stability of caffeine oral formulations for neonatal use. J. Clin. Pharm. Ther. 19:1994;391-396.
32. Wasfi I.A., Boni N.S., Elghazali M., Abdel Hadi A.A., Almuhrami A.M., Barezaig I.M., Alkatheeri N.A. The pharmacokinetics, metabolism and urinary detection time of caffeine in camels. Res.Vet. Sci. 69:2000;69-74.